Related Experiment Video

Updated: May 22, 2026

Improved Lipofuscin Models and Quantification of Outer Segment Phagocytosis Capacity in Highly Polarized Human Retinal Pigment Epithelial Cultures
10:39

Improved Lipofuscin Models and Quantification of Outer Segment Phagocytosis Capacity in Highly Polarized Human Retinal Pigment Epithelial Cultures

Published on: April 14, 2023

Lipofuscin hypothesis of Alzheimer's disease

Giorgio Giaccone1, Laura Orsi, Chiara Cupidi

  • 1Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Palermo, Italy.

Dementia and Geriatric Cognitive Disorders Extra
|May 1, 2012
PubMed

Insights

Alzheimer's disease (AD) cause is unknown. This study hypothesizes that lipofuscin, an age-related product, may contribute to amyloid plaque formation in AD, offering a new perspective on disease pathology.

Area of Science:

  • Neuroscience
  • Pathology
  • Aging Research

Background:

  • The exact cause of Alzheimer's disease (AD) remains elusive.
  • Amyloid-beta (Aβ) is a key component of senile plaques, but its role as the primary trigger for AD pathogenesis is debated.
  • Existing theories do not fully explain all pathological events in sporadic AD.

Purpose of the Study:

  • To propose a novel hypothesis regarding the pathogenesis of Alzheimer's disease.
  • To highlight the potential role of lipofuscin, an age-related cellular accumulation, in AD.
  • To suggest lipofuscin release contributes to senile plaque formation.

Main Methods:

  • Literature review and hypothesis formulation.
  • Comparative analysis of AD and age-related macular degeneration.
  • Examination of intraneuronal Aβ and extracellular Aβ deposition.

Main Results:

  • Lipofuscin is an age-related product accumulating within neurons.
  • Neuronal death may lead to extracellular release of lipofuscin.
  • Extracellular lipofuscin could contribute to the formation of amyloid plaques.

Conclusions:

  • Lipofuscin's extracellular release is a plausible contributing factor to senile plaque formation in AD.
  • This hypothesis offers a potential explanation for previously unexplained aspects of AD.
  • Further research is warranted to investigate the link between lipofuscin and Alzheimer's disease pathology.
Keywords:
Alzheimer's diseaseAmyloidAβ proteinLipofuscinMacular degenerationNeurofibrillary tangles

More Related Videos

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining07:32

Assessing Iron Deposition in the Brains of 5xFAD Mice by Perls'/DAB Staining

Published on: May 23, 2025

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Dementia l: Introduction01:22

Dementia l: Introduction

Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...